There are 4 repositories under pk-sim topic.
PK-Sim® is a comprehensive software tool for whole-body physiologically based pharmacokinetic modeling
Physiologically Based Pharmacokinetic Models for Pregnant Women
Whole-body PBPK model of digoxin as P-gp DDI victim drug
Whole-body PBPK model of Vancomycin
Whole-body PBPK model of voriconazole as CYP2C19 substrate and CYP3A4 perpetrator drug
PK-Sim® & MoBi® workshop on integrating PBPK with QSP
Modeling of published clinical Carbamazepine-Alprazolam-DDI studies for model evaluation
Modeling of published clinical Carbamazepine-Efavirenz DDI studies for model evaluation
Modeling of published clinical Carbamazepine-Midazolam-DDI studies for model evaluation
Modeling of published clinical Cimetidine-Alfentanil-DDI studies for model evaluation
Modeling of published clinical Cimetidine-Alprazolam-DDI studies for model evaluation
Modeling of published clinical Cimetidine-Carbamazepine DDI studies for model evaluation
Modeling of published clinical Cimetidine-Midazolam-DDI studies for model evaluation
Whole-body PBPK model of cimetidine (OCT2/MATE and CYP3A4 DDI perpetrator drug)
Modeling of published clinical Cimetidine-Triazolam-DDI studies for model evaluation
Modeling of published clinical Cimetidine-Verapamil-DDI studies for model evaluation
Modeling of published clinical Clarithromycin-Midazolam-DDI studies for model evaluation
Modeling of published clinical Erythromycin-Carbamazepine DDI studies for model evaluation
Modeling of published clinical Itraconazole-Digoxin-DDI studies for model evaluation
Whole-body PBPK model of itraconazole as CYP3A4 and P-gp DDI perpetrator drug
Whole-body PBPK model of levonorgestrel with and without ethinyl estradiol as CYP3A4 DDI victim drug
PBPK model of metoprolol and metoprolol-CYP2D6 drug-gene interactions
Whole-body PBPK model of theophylline as CYP1A2 DDI victim drug